idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
10/28/2025 14:52

Protecting the gut after stem cell transplantation: New evidence for the potential of microbiome-based therapies

Clara Stark Stabsstelle „Strategische Entwicklung“
Leibniz-Institut für Immuntherapie

    Patients receiving intensive cancer treatments - such as radiation or stem cell transplantation - often suffer from severe damage to the intestinal lining. This not only causes pain and complications but also worsens long-term outcomes. A “Nature Communications” study from the LIT Cooperation Group “Innate Immune Sensing in Cancer and Transplantation” reveals how a microbial metabolite safeguards the intestinal barrier and drives stem cell-mediated regeneration after injury. The results also show that the microbial product simultaneously reinforces the immune defense against leukemia.

    A microbial product from our diet protects the gut during cancer therapy - and this effect represents an important advance in the treatment of severe side effects of cancer and transplant therapies. “Desaminotyrosine stimulates stem-cell repair and fine-tunes immunity using nutrient- and danger-sensing pathways,” describes PhD student Sascha Göttert at the Clinic and Polyclinic for Internal Medicine III at University Hospital Regensburg (UKR) and first author of the study. Together with Prof. Hendrik Poeck, Head of the LIT Cooperation Group “Innate Immune Sensing in Cancer and Transplantation” and Dr. Erik Thiele Orberg, Senior Physician at UKR, he led the research team.

    The study by the LIT Cooperation Group in collaboration with researchers from the Technical University of Munich (TUM) opens exciting prospects for developing microbiome-based therapies to enhance recovery and outcomes after stem cell transplantation. The team was supported by the Collaborative Research Centre (CRC) 1371 initiative to understand the functional relevance of microbiome signatures and to determine their precise contribution in a disease-specific manner, as well as by the CRC Transregio 221, which focuses on unsolved challenges in the treatment of patients with leukemia or lymphoma.

    A gut-microbe metabolite that shields against transplant complications

    Desaminotyrosine (DAT) is a small molecule produced when gut bacteria break down dietary flavonoids found in fruits and vegetables. “The effect of DAT was observed even under broad-spectrum antibiotics, which, while often unavoidable, are linked to worse outcomes and remain a major limitation of allogenic stem-cell transplants,” explains Dr. Erik Thiele Orberg, shared first author of the study.

    In patients who underwent stem cell transplantation, higher DAT levels were associated with better survival and fewer relapses. In preclinical mouse models, synthetic DAT even prevented the dangerous complication known as graft-versus-host disease (GvHD) by strengthening the intestinal barrier and boosting tissue repair. This effect was observed even though the animals had lost much of their healthy gut flora due to antibiotics.

    Small “mini intestines”: modern organoid cultures used to analyze the effects

    The researchers examined tissue samples from patients who had undergone stem cell transplantation, as well as various mouse models for radiation- and therapy-induced intestinal damage. In addition, modern organoid cultures - small “mini-intestines” made from human stem cells in the laboratory were used to specifically analyze the effects of the bacterial metabolite on the intestinal lining.

    Activating intestinal stem cells and anti-cancer effects: progress for treatment options

    DAT worked by activating intestinal stem cells and supporting them during stress, while also contributing to immune responses to retain anti-cancer effects. Therefore, this important study emphasizes the significance of intestinal stem cells, underscoring their central role as “master repairers.” As Prof. Hendrik Poeck, Head of the LIT Cooperation Group “Innate Immune Sensing in Cancer and Transplantation,” says, “these findings open exciting avenues for new microbiome-based treatments that could reduce side effects, improve quality of life, and enhance the effectiveness of life-saving therapies.”

    About the Leibniz Institute for Immunotherapy (LIT)

    The LIT is an institute within the Leibniz Association located in Regensburg, Germany. Our mission is to develop innovative therapies for the treatment of cancer, autoimmunity, and chronic inflammation. By reprogramming immune cells through synthetic and pharmacological strategies, we build cells that save lives.


    Contact for scientific information:

    Prof. Dr. med. Hendrik Poeck
    Head of LIT Cooperation Group Innate Immune Sensing in Cancer & Transplantation

    LIT – Leibniz Institute for Immunotherapy
    c/o University Hospital Regensburg
    Franz-Josef-Strauß-Allee 11
    93053 Regensburg, Germany

    phone: +49 941 944-5542
    email: hendrik.poeck@klinik.uni-regensburg.de

    Managing Senior Physician
    Leukemias, Stem cell transplantation & Cellular therapies
    Klinik und Poliklinik für Innere Medizin III (Hämatologie und Onkologie)
    Universitätsklinikum Regensburg


    Original publication:

    Göttert, S., Thiele Orberg, E., Fan, K. et al. The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration. Nat Commun 16, 9282 (2025). https://doi.org/10.1038/s41467-025-65180-6


    Images

    Modern organoid cultures - small “mini-intestines” - are made from human stem cells in the laboratory.
    Modern organoid cultures - small “mini-intestines” - are made from human stem cells in the laborator ...
    Source: Sascha Göttert
    Copyright: © LIT

    From left to right: Dr. Erik Thiele Orberg, Sascha Göttert and Prof. Hendrik Poeck
    From left to right: Dr. Erik Thiele Orberg, Sascha Göttert and Prof. Hendrik Poeck
    Source: Clara Stark
    Copyright: © LIT


    Criteria of this press release:
    Journalists, Scientists and scholars, Students
    Biology, Medicine, Nutrition / healthcare / nursing
    transregional, national
    Research results, Scientific Publications
    English


     

    Modern organoid cultures - small “mini-intestines” - are made from human stem cells in the laboratory.


    For download

    x

    From left to right: Dr. Erik Thiele Orberg, Sascha Göttert and Prof. Hendrik Poeck


    For download

    x

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).